Clinical outcomes of bortezomib-based therapy in myeloma

Faouzi Djebbari; Anandagopal Srinivasan; Grant Vallance; Sally Moore; Jaimal Kothari; Karthik Ramasamy

doi:10.1371/journal.pone.0208920

Loading metrics

Open Access

Peer-reviewed

Research Article

Clinical outcomes of bortezomib-based therapy in myeloma

Faouzi Djebbari ,

Contributed equally to this work with: Faouzi Djebbari, Anandagopal Srinivasan

Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Writing – original draft

* E-mail: faouzi.djebbari@ouh.nhs.uk

Affiliation Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom

http://orcid.org/0000-0001-9578-7632

⨯
Anandagopal Srinivasan ,

Contributed equally to this work with: Faouzi Djebbari, Anandagopal Srinivasan

Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing – review & editing

Affiliation Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
⨯
Grant Vallance,

Roles Project administration, Resources

Affiliation Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
⨯
Sally Moore,

Roles Formal analysis, Writing – review & editing

Affiliation Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
⨯
Jaimal Kothari,

Roles Formal analysis, Writing – review & editing

Affiliations Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom, NIHR BRC Blood Theme, Oxford, United Kingdom, Oxford Myeloma Centre for Translational Research, Oxford, United Kingdom
⨯
Karthik Ramasamy

Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Supervision, Validation, Writing – review & editing

Affiliations Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom, NIHR BRC Blood Theme, Oxford, United Kingdom, Oxford Myeloma Centre for Translational Research, Oxford, United Kingdom
⨯

Clinical outcomes of bortezomib-based therapy in myeloma

Faouzi Djebbari,
Anandagopal Srinivasan,
Grant Vallance,
Sally Moore,
Jaimal Kothari,
Karthik Ramasamy

Published: December 12, 2018
https://doi.org/10.1371/journal.pone.0208920

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Routes of administration
Is the Subject Area "Routes of administration" applicable to this article?

Thanks for your feedback.
Multiple myeloma
Is the Subject Area "Multiple myeloma" applicable to this article?

Thanks for your feedback.
Toxicity
Is the Subject Area "Toxicity" applicable to this article?

Thanks for your feedback.
Myeloma
Is the Subject Area "Myeloma" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Stem cell therapy
Is the Subject Area "Stem cell therapy" applicable to this article?

Thanks for your feedback.
Frailty
Is the Subject Area "Frailty" applicable to this article?

Thanks for your feedback.
Intravenous injections
Is the Subject Area "Intravenous injections" applicable to this article?

Thanks for your feedback.